KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Novartis Ag (NVS) Shares Repurchased (2017 - 2025)

Historic Shares Repurchased for Novartis Ag (NVS) over the last 7 years, with Q4 2025 value amounting to -$1.5 billion.

  • Novartis Ag's Shares Repurchased rose 4641.56% to -$1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$9.2 billion, marking a year-over-year decrease of 1057.5%. This contributed to the annual value of -$9.2 billion for FY2025, which is 1057.5% down from last year.
  • Latest data reveals that Novartis Ag reported Shares Repurchased of -$1.5 billion as of Q4 2025, which was up 4641.56% from -$2.3 billion recorded in Q3 2025.
  • Novartis Ag's 5-year Shares Repurchased high stood at -$1.1 billion for Q1 2024, and its period low was -$3.0 billion during Q2 2023.
  • Over the past 4 years, Novartis Ag's median Shares Repurchased value was -$2.7 billion (recorded in 2022), while the average stood at -$2.3 billion.
  • Per our database at Business Quant, Novartis Ag's Shares Repurchased skyrocketed by 6191.96% in 2024 and then tumbled by 14713.38% in 2025.
  • Over the past 4 years, Novartis Ag's Shares Repurchased (Quarter) stood at -$2.7 billion in 2022, then surged by 53.29% to -$1.3 billion in 2023, then crashed by 120.78% to -$2.8 billion in 2024, then surged by 46.42% to -$1.5 billion in 2025.
  • Its last three reported values are -$1.5 billion in Q4 2025, -$2.3 billion for Q3 2025, and -$2.7 billion during Q2 2025.